Sigma-Aldrich (Nasdaq: SIAL) Q3 2007 Sales Increase 14.0%, Yielding Diluted EP...(rates for both Q3 2007 and the first nin...)

Date:10/23/2007

rates for both Q3 2007 and the first nine months of 2007 compared to the same periods in 2006 reflect a net tax charge of approximately $4.0 million in Q3 2007 to revalue deferred tax assets and liabilities in Germany and the U.K. and a tax audit benefit in Q3 2006 of approximately $4.0 million. Other items impacting year-to-date tax rate comparisons include a lower level of international taxes in 2007, an increase in the U.S. manufacturing deduction in 2007 and the reinstatement of R&D tax credits in Q4 2006, partially offset by the expiration of U.S. export tax benefits at the end of 2006.

OUTLOOK:

2007 Performance: Ongoing implementation of programs supporting our five key strategic initiatives is expected to provide organic sales growth of approximately 7% for all of 2007.

With above target performance in both the second and third quarters of 2007, Research Essentials is expected to meet or slightly exceed its long-term organic growth target of 4% for the full year.

The activities that have driven above target growth in Research Specialties through the second half of 2006 and the first three quarters of 2007 are expected to drive growth of at least 6% during Q4 2007. Despite tougher comparisons to its best sales performance in Q4 2006, such growth will enable this unit to exceed its long-term organic growth goal for full year 2007, delivering growth in excess of 7%.

Research Biotech is expected to maintain improved organic sales growth compared to first half performance for the final quarter of 2007, resulting in 6% organic growth for the second half of 2007. This unit will continue to benefit from increased sales efforts launched early in the year, the continued addition of innovative products to our broad offering, the listing of some of our biotechnology products in new public databases, the availability of new tools to more quickly locate our products during web searches and the Q3 2007 addition of new product licenses with Sang
'/>"/>

SOURCE Sigma-Aldrich Copyright©2007 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Related biology technology :

1. Jellyfish partners for sales tracking technology
2. Doyle wants sales tax applied to digital downloads
3. Mortgagebot builds online sales even as housing declines
4. Third Wave reports another loss, stronger sales
5. Johnson Controls reports record quarterly sales
6. Can sales outsourcing grow Wisconsin biotechs?
7. Sonic Foundry reports quarterly loss, higher Mediasite sales
8. My-oh, its BIO! Where sales hype and science collide
9. Third Wave shuffles finance, sales management
10. Johnson Controls sales up, profits down
11. Turning ads into sales: Context is king